Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Imaging is Scopus-indexed (Q1, CiteScore 5.9), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1470-7330Verify ISSN ↗1740-5025Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 64 / 361 | 82nd | Q1 |
| Oncology | 113 / 428 | 73rd | Q2 |
| Radiological and Ultrasound Technology | 18 / 64 | 72nd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2000–present, best quartile Q1, CiteScore 5.9.
Cancer Imaging is Q1 in Radiology, Nuclear Medicine and Imaging (rank 64 of 361), Q2 in Oncology (rank 113 of 428) and Q2 in Radiological and Ultrasound Technology (rank 18 of 64), by CiteScore 2025.
Cancer Imaging is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.9, which places it in quartile Q1 at the 82nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.160, quartile Q1, with an H-index of 73.
The publisher lists an article processing charge of about US$2,790 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cancer Imaging is published by BioMed Central Ltd. Its print ISSN is 1470-7330 and its online ISSN is 1740-5025.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Cancer Imaging has an h-index of 83 and a 2-year mean of 5.16 citations per paper (OpenAlex). Its Scopus CiteScore is 5.9, quartile Q1. On 2-year citations it ranks #22 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Cancer Imaging published 159 papers in 2025; its busiest recent year was 2024 with 173. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (53.2%), United States (8.8%) and Germany (6.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 8 retracted papers are recorded (3.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.